6 results
Cauda Equina Syndrome Overview

Cauda Equina Syndrome:
 • Prevalence: 1:33,000-100,000 ppl/yr
 • Incidence: 1.5-3.4 million ppl/yr
 •
Cauda Equina Syndrome ... toon • Spinal infection ... /abscess • Ankylosing ... axial T1 and T2 Treatment ... diagnosis #causes #neurology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... detailed application instructions ... candida #mucosal #IDSA ... opportunistic #infections ... #HIVAIDS #pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
response preceding infection ... roots and cauda equina ... Treatment: • Plasmapheresis ... diagnosis #management #treatment ... #neurology
Lesions of the Spinal cord - Spinal Cord Syndromes

Spinal cord lesions can result in permanent neurologic
result in permanent neurologic ... Spinal stenosis - Abscess ... Infarction - Infection ... involvement Cauda Equina ... differential #diagnosis #neurology
Guillain-Barré Syndrome (GBS)
Acute autoimmune demyelinating polyradiculoneuropathy that presents with rapidly progressive flaccid weakness
Epidemiology:
 • Incidence: 1
Guillain-Barré Syndrome ... roots and cauda equina ... TREATMENT • Plasmapheresis ... Guillain #Barre #Syndrome ... diagnosis #management #neurology
IDSA Recommendations for Treating Coccidiodomycosis in HIV-AIDS
Treating Mild Infections (Such As Focal Pneumonia or asymptomatic patients
IDSA Recommendations ... with positive serology ... improvement, then switch to ... #Prevention #Treatment ... #HIVAIDS #pharmacology